Open original FDA record ↗Recall record
- FDA identifier
- Z-1415-2021
- Company in FDA record
- EOS Imaging
- FDA record creation date
- Apr 13, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Inadequate images resizing and 2D measurement errors may occur when biplanar acquisition has been performed with patient orientation different from AP (Antero-Posterior).
Source facts
- Action
- A recall notification letter titled, "Field Safety Notice (FSN1 REG-2020-0001-A) Safety information concerning the EOSedge imaging device, was sent to the US consignees on 12/22/2020 via certified mail, followed by a phone call to one of the consignees and hand delivery to the other U.S. consignee. The OUS consignees were provided notification beginning on 12/30/2020 either by sending of a certified mail plus an email to direct customer consignees or by sending of an email to distributors for countries where the EOSedge distribution is not made directly by EOS imaging, i.e. Australia and Spain. The consignee is requested to: 1) Please read the field safety notice. 2) Follow the instructions provided in this field safety notice. 3) Please transfer this notice to whomever needs to be informed within the consignee's organization or in any organization to which the device may have been transferred. The instructions provided in the notice goes as follows: "EOSedge users are requested not to combine acquisition of patients in orientation different than AP with reference plane modification at REVIEW step. Users of the sterEOS workstation are requested to systematically display reference planes and check they are properly positioned before performing modeling or measurement, sending to PACS and carrying out a diagnosis. Same verification can be performed on sterEOS with images previously acquired, and correction can be applied for retrospective measurements if necessary."
- Initiated
- 2020-12-22
- Root cause
- Software design
- Terminated
- 2023-05-05
- Distribution
- Distributed nationwide to MN, OH and internationally to Australia, Canada, Germany, Spain, and France
- Recall number
- Z-1415-2021
- Recall status
- Terminated
- CDRH record ID
- 186202
- FDA record created
- 2021-04-13
- Recall event number
- 87505